Naviter Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Naviter Wealth, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $46.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$46.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 9,534 | $8.8M |
| AZNASTRAZENECA PLC | 31,249 | $6.2M |
| NVSNovartis AG | 38,815 | $5.9M |
| JNJJOHNSON & JOHNSON | 20,734 | $5.1M |
| ABBVAbbVie Inc. | 16,738 | $3.6M |
| MRKMerck & Co., Inc. | 21,629 | $2.6M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 43,754 | $2.4M |
| ABTABBOTT LABORATORIES | 23,296 | $2.4M |
| AMGNAMGEN INC | 6,370 | $2.2M |
| PFEPFIZER INC | 48,172 | $1.4M |
| NVONovo Nordisk A/S | 34,012 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,305 | $1.2M |
| PMPhilip Morris International Inc | 5,587 | $932K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 44,701 | $828K |
| ARGXARGENX SE | 800 | $584K |
| ELVElevance Health Inc. | 945 | $277K |
| BMYBRISTOL MYERS SQUIBB CO | 3,933 | $239K |
| MEDPMedpace Holdings Inc. | 433 | $208K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.